Characterizing clonal expansion of large mosaic chromosomal alterations in leukocytes |
Mitchell Machiela |
National Cancer Institute |
PLCO |
Jun 14, 2021 |
2021-0014 |
Using circulating metabolomes to understand pancreatic cancer genotype and phenotype and to explore their potential for risk assessment and early detection |
Herbert Yu |
University of Hawaii Cancer Center |
PLCO |
Jun 14, 2021 |
2021-0013 |
The impact of pregnancy history on genome-wide methylation patterns in women with and without multiple sclerosis |
Vilija Jokubaitis |
Monash University |
PLCO |
May 21, 2021 |
PLCO-789 |
PLCO: Effects of high-dimensional genetic variation (GWAS) on PSA trajectories and their relationship with prostate cancer incidence |
Grace Hong |
NCI |
PLCO |
May 18, 2021 |
PLCO-787 |
Opioid Cohort Consortium (OPICO) to investigate the effects of opioid use on cancer incidence and mortality |
Mahdi Sheikh |
Internatioanl Agency for Research on Cancer (IARC - WHO) |
PLCO |
May 11, 2021 |
PLCO-784 |
AI system to infer a patient’s prostate cancer stage from clinical information trained on synthetic electronic health records |
Ali Kamen |
Siemens Healthineers |
PLCO |
May 11, 2021 |
PLCO-786 |
Decisions to perform invasive diagnostic procedures follow a probability curve based upon the risk of cancer: insights from lung, ovarian and prostate cancer from the PLCO dataset |
Fabien Maldonado |
Vanderbilt University Medical Center |
PLCO |
May 7, 2021 |
PLCO-778 |
Associations of inflammatory and insulinemic dietary patterns and risk of colorectal adenomas in men and women: Findings from the PLCO cohort |
Fred Tabung |
The Ohio State University |
PLCO |
May 7, 2021 |
PLCO-780 |
Joint modeling of longitudinal data and survival data in hidden markov model setting |
hong li |
medical university of south carolina |
PLCO |
May 7, 2021 |
PLCO-782 |
Statistical methods issues for biomarker studies in cancer screening trials |
Ping Hu |
NCI |
PLCO |
Apr 30, 2021 |
PLCO-779 |
Efficient machine learning algorithms for investigating and comparing the risk factors of breast and prostate cancers among males and females |
Samaneh Rikhtehgaran |
Florida Atlantic University |
PLCO |
Apr 21, 2021 |
PLCO-777 |
Dynamic Risk Prediction of Prostate Cancer Development Using Longitudinal Biomarkers of PSA |
Ming Wang |
The Pennsylvania State University |
PLCO |
Apr 20, 2021 |
PLCO-775 |
Impact of Exercise on Cancer Pathogenesis |
Lee Jones |
Memorial Sloan Kettering Cancer Center |
PLCO |
Apr 19, 2021 |
PLCO-769 |
A systematic review of the benefits of screening never smokers who have a high risk of lung cancer |
Brent White |
Western Sydney University |
PLCO |
Apr 16, 2021 |
PLCO-765 |
Thyroid disease prediction using machine learning algorithm |
Sneha Maria George |
Christ(Deemed to be University) |
PLCO |
Apr 16, 2021 |
PLCO-773 |
Predicting risk of cancer in 12 sites using the screened arm of the PLCO |
Grant Izmirlian |
National Cancer Institute |
PLCO |
Apr 5, 2021 |
PLCO-762 |
Investigation of alternative screening trial endpoints |
Philip Prorok |
NC I |
PLCO |
Apr 5, 2021 |
PLCO-761 |
Development and Validation of a Head and Neck Cancer Risk Prediction Model |
John Cramer |
Karmanos Cancer Institute |
PLCO |
Apr 5, 2021 |
PLCO-760 |
Bayesian hierarchical change point model with variable selections in hidden Markov model setting |
Hong Li |
medical university of south carolina |
PLCO |
Apr 5, 2021 |
PLCO-759 |
Adolescent and adulthood BMI And Cancer risk using obese-year metrics: the ABACus 2 project |
Andrew Renehan |
University of Manchester |
PLCO |
Mar 30, 2021 |
PLCO-752 |